200 related articles for article (PubMed ID: 25721401)
1. Complex I assembly function and fatty acid oxidation enzyme activity of ACAD9 both contribute to disease severity in ACAD9 deficiency.
Schiff M; Haberberger B; Xia C; Mohsen AW; Goetzman ES; Wang Y; Uppala R; Zhang Y; Karunanidhi A; Prabhu D; Alharbi H; Prochownik EV; Haack T; Häberle J; Munnich A; Rötig A; Taylor RW; Nicholls RD; Kim JJ; Prokisch H; Vockley J
Hum Mol Genet; 2015 Jun; 24(11):3238-47. PubMed ID: 25721401
[TBL] [Abstract][Full Text] [Related]
2. ACAD9, a complex I assembly factor with a moonlighting function in fatty acid oxidation deficiencies.
Nouws J; Te Brinke H; Nijtmans LG; Houten SM
Hum Mol Genet; 2014 Mar; 23(5):1311-9. PubMed ID: 24158852
[TBL] [Abstract][Full Text] [Related]
3. Neonatal multiorgan failure due to ACAD9 mutation and complex I deficiency with mitochondrial hyperplasia in liver, cardiac myocytes, skeletal muscle, and renal tubules.
Leslie N; Wang X; Peng Y; Valencia CA; Khuchua Z; Hata J; Witte D; Huang T; Bove KE
Hum Pathol; 2016 Mar; 49():27-32. PubMed ID: 26826406
[TBL] [Abstract][Full Text] [Related]
4. Acyl-CoA dehydrogenase 9 is required for the biogenesis of oxidative phosphorylation complex I.
Nouws J; Nijtmans L; Houten SM; van den Brand M; Huynen M; Venselaar H; Hoefs S; Gloerich J; Kronick J; Hutchin T; Willems P; Rodenburg R; Wanders R; van den Heuvel L; Smeitink J; Vogel RO
Cell Metab; 2010 Sep; 12(3):283-94. PubMed ID: 20816094
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of mitochondrial bioenergetics, dynamics, endoplasmic reticulum-mitochondria crosstalk, and reactive oxygen species in fibroblasts from patients with complex I deficiency.
Leipnitz G; Mohsen AW; Karunanidhi A; Seminotti B; Roginskaya VY; Markantone DM; Grings M; Mihalik SJ; Wipf P; Van Houten B; Vockley J
Sci Rep; 2018 Jan; 8(1):1165. PubMed ID: 29348607
[TBL] [Abstract][Full Text] [Related]
6. Severe defect in mitochondrial complex I assembly with mitochondrial DNA deletions in ACAD9-deficient mild myopathy.
Fragaki K; Chaussenot A; Boutron A; Bannwarth S; Cochaud C; Richelme C; Sacconi S; Paquis-Flucklinger V
Muscle Nerve; 2017 Jun; 55(6):919-922. PubMed ID: 27438479
[TBL] [Abstract][Full Text] [Related]
7. A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency.
He M; Rutledge SL; Kelly DR; Palmer CA; Murdoch G; Majumder N; Nicholls RD; Pei Z; Watkins PA; Vockley J
Am J Hum Genet; 2007 Jul; 81(1):87-103. PubMed ID: 17564966
[TBL] [Abstract][Full Text] [Related]
8. Lifetime exercise intolerance with lactic acidosis as key manifestation of novel compound heterozygous ACAD9 mutations causing complex I deficiency.
Schrank B; Schoser B; Klopstock T; Schneiderat P; Horvath R; Abicht A; Holinski-Feder E; Augustis S
Neuromuscul Disord; 2017 May; 27(5):473-476. PubMed ID: 28279569
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of a mouse model for Acad9 deficiency.
Sinsheimer A; Mohsen AW; Bloom K; Karunanidhi A; Bharathi S; Wu YL; Schiff M; Wang Y; Goetzman ES; Ghaloul-Gonzalez L; Vockley J
Mol Genet Metab; 2021; 134(1-2):156-163. PubMed ID: 34556413
[TBL] [Abstract][Full Text] [Related]
10. Assembly defects of multiple respiratory chain complexes in a child with cardiac hypertrophy associated with a novel ACAD9 mutation.
Fragaki K; Chaussenot A; Boutron A; Bannwarth S; Rouzier C; Chabrol B; Paquis-Flucklinger V
Mol Genet Metab; 2017 Jul; 121(3):224-226. PubMed ID: 28529009
[TBL] [Abstract][Full Text] [Related]
11. Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency.
Haack TB; Danhauser K; Haberberger B; Hoser J; Strecker V; Boehm D; Uziel G; Lamantea E; Invernizzi F; Poulton J; Rolinski B; Iuso A; Biskup S; Schmidt T; Mewes HW; Wittig I; Meitinger T; Zeviani M; Prokisch H
Nat Genet; 2010 Dec; 42(12):1131-4. PubMed ID: 21057504
[TBL] [Abstract][Full Text] [Related]
12. Riboflavin-responsive oxidative phosphorylation complex I deficiency caused by defective ACAD9: new function for an old gene.
Gerards M; van den Bosch BJ; Danhauser K; Serre V; van Weeghel M; Wanders RJ; Nicolaes GA; Sluiter W; Schoonderwoerd K; Scholte HR; Prokisch H; Rötig A; de Coo IF; Smeets HJ
Brain; 2011 Jan; 134(Pt 1):210-9. PubMed ID: 20929961
[TBL] [Abstract][Full Text] [Related]
13. Evidence of a wide spectrum of cardiac involvement due to ACAD9 mutations: Report on nine patients.
Dewulf JP; Barrea C; Vincent MF; De Laet C; Van Coster R; Seneca S; Marie S; Nassogne MC
Mol Genet Metab; 2016 Jul; 118(3):185-189. PubMed ID: 27233227
[TBL] [Abstract][Full Text] [Related]
14. High incidence and variable clinical outcome of cardiac hypertrophy due to ACAD9 mutations in childhood.
Collet M; Assouline Z; Bonnet D; Rio M; Iserin F; Sidi D; Goldenberg A; Lardennois C; Metodiev MD; Haberberger B; Haack T; Munnich A; Prokisch H; Rötig A
Eur J Hum Genet; 2016 Aug; 24(8):1112-6. PubMed ID: 26669660
[TBL] [Abstract][Full Text] [Related]
15. An atypical presentation of ACAD9 deficiency: Diagnosis by whole exome sequencing broadens the phenotypic spectrum and alters treatment approach.
Aintablian HK; Narayanan V; Belnap N; Ramsey K; Grebe TA
Mol Genet Metab Rep; 2017 Mar; 10():38-44. PubMed ID: 28070495
[TBL] [Abstract][Full Text] [Related]
16. Dynamic simulations on the mitochondrial fatty acid beta-oxidation network.
Modre-Osprian R; Osprian I; Tilg B; Schreier G; Weinberger KM; Graber A
BMC Syst Biol; 2009 Jan; 3():2. PubMed ID: 19126203
[TBL] [Abstract][Full Text] [Related]
17. Optic neuropathy linked to ACAD9 pathogenic variants: A potentially riboflavin-responsive disorder?
Gueguen N; Piarroux J; Sarzi E; Benkirane M; Manes G; Delettre C; Amedro P; Leboucq N; Koenig M; Meyer P; Meunier I; Reynier P; Lenaers G; Roubertie A
Mitochondrion; 2021 Jul; 59():169-174. PubMed ID: 34023438
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship.
Gregersen N; Andresen BS; Corydon MJ; Corydon TJ; Olsen RK; Bolund L; Bross P
Hum Mutat; 2001 Sep; 18(3):169-89. PubMed ID: 11524729
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial fatty acid oxidation defects--remaining challenges.
Gregersen N; Andresen BS; Pedersen CB; Olsen RK; Corydon TJ; Bross P
J Inherit Metab Dis; 2008 Oct; 31(5):643-57. PubMed ID: 18836889
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel mitochondrial complex I assembly factor ACDH-12 in Caenorhabditis elegans.
Chuaijit S; Boonyatistan W; Boonchuay P; Metheetrairut C; Suthammarak W
Mitochondrion; 2019 May; 46():91-96. PubMed ID: 29540318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
